Industry Collaboration and Randomized Clinical Trial Design and Outcomes
Author(s) -
Nitin Roper,
Nasen Zhang,
Deborah Korenstein
Publication year - 2014
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2014.3590
Subject(s) - medicine , randomized controlled trial , research design , medline , physical therapy , intensive care medicine , medical physics , social science , sociology , political science , law
Industry Collaboration and Randomized Clinical Trial Design and Outcomes Industry-funded clinical trials are more likely to have favorable, proindustry results compared with nonindustry funded trials,1 but few studies have distinguished between industry funding in the context of industry collaboration in the design, analysis, or reporting of trials.2,3 For a sample of clinical trials published in high-impact journals, our objective was to examine whether industry funding with collaboration was associated with certain trial design features and outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom